Clinical Research in Cardiology

, Volume 96, Issue 11, pp 767–786

Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007

(FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I–III, ARISE, getABI, RIO)
  • Michael Kindermann
  • Oliver Adam
  • Nikos Werner
  • Michael Böhm
CLINICAL TRIALS UPDATE AND HOTLINES

DOI: 10.1007/s00392-0591-z

Cite this article as:
Kindermann, M., Adam, O., Werner, N. et al. Clin Res Cardiol (2007) 96: 767. doi:10.1007/s00392-0591-z

Abstract

This article provides information and commentaries on trials which were presented at the Hotline and Clinical Trial Update Sessions at the European Society of Cardiology Congress 2007 in Vienna. The key presentations were performed by leading experts in the field with relevant positions in the trials or registries. It is important to note that unpublished reports should be considered as preliminary data, as the analysis may change in the final publications. The comprehensive summaries have been generated from the oral presentation and the webcasts of the European Society of Cardiology and should provide the readers with the most comprehensive information of relevant publications.

Key words

FINESSE CARESS OASIS 5 PRAGUE-8 OPTIMIST GRACE STEEPLE SCAAR STRATEGY DANAMI-2 ExTRACT-TIMI-25 ISAR-REACT 2 ACUITY ALOFT 3CPO PROSPECT EVEREST COACH BENEFiT MERLIN-TIMI 36 SEARCH-MI ADVANCE WENBIT EUROASPIRE I–III ARISE getABI RIO 

Abbreviations

ACS

acute coronary syndrome

ACE-I

angiotensin converting enzyme inhibitor

AMI

acute myocardial infarction

ABI

ankle brachial index

ARB

angiotensin receptor blocker

BMS

bare metal stents

CABG

coronary artery bypass grafting

CAD

coronary artery disease

CHF

congestive heart failure

CI

confidence interval

DES

drug eluting stents

DRI

direct renin inhibitor

GpIIb/IIIa

glycoprotein IIb IIIa

HR

hazard ratio

MACE

major adverse cardiovascular events

MI

myocardial infarction

NS

not significant

NSTE-ACS

non-ST-segment elevation acute coronary syndrome

NSTEMI

non-ST-segment elevation myocardial infarction

NYHA

New York Heart Association

OR

odds ratio

PCI

percutaneous coronary intervention

PAD

peripheral arterial disease

RAAS

renin-angiotensin-aldosterone system

RR

relative risk

STEMI

ST-segment elevation myocardial infarction

TVR

target vessel revascularization

TIMI

thrombolysis in myocardial infarction group

UFH

unfractionated heparin

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • Michael Kindermann
    • 1
  • Oliver Adam
    • 1
  • Nikos Werner
    • 2
  • Michael Böhm
    • 1
  1. 1.Klinik für Innere Medizin IIIUniversitätsklinikum des SaarlandesHomburg/SaarGermany
  2. 2.Medizinische Klinik und Poliklinik IIUniversitätsklinikum BonnBonn

Personalised recommendations